Control of the radicality of brain tumor removal using intraoperative ultrasound imaging
- Authors: Dyshchirov Y.Y.1, Mitina L.A.1, Zaitsev A.M.1, Stepanov S.S.1, Kirsanova O.N.1, Guts O.V.1, Ruban M.S.1
-
Affiliations:
- P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
- Issue: Vol 15, No 4 (2025)
- Pages: 18-24
- Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
- Published: 18.03.2026
- URL: https://ogsh.abvpress.ru/jour/article/view/1092
- DOI: https://doi.org/10.17650/2222-1468-2025-15-4-18-24
- ID: 1092
Cite item
Full Text
Abstract
Introduction. Achieving maximal radical resection is a critical factor influencing the prognosis of patients with brain tumors. Intraoperative ultrasound (IOUS) is a promising method for intraoperative control; however, its role in assessing resection radicality and intraoperative decision-making requires further study.
Aim. To evaluate the effectiveness of IOUS for monitoring the radical resection of primary and metastatic brain tumors.
Materials and methods. A prospective study included 58 patients who underwent surgery between January 2023 and September 2024. All patients underwent repeated IOUS in B-mode and with contrast enhancement after the main tumor volume removal to detect residual tumor tissue.
Results. Repeated IOUS identified residual tumor foci (minimum size up to 4 mm) in 17 (29.3 %) patients, leading to continued resection and achieving total or subtotal resection in 100 % of cases. The method provided visualization of tumor boundaries, differentiation from perifocal edema, and monitoring of intraoperative complications.
Conclusion. Intraoperative ultrasound is a highly informative, cost-effective, and safe method that significantly improves the radicality of neurosurgical interventions and can be recommended for widespread integration into clinical practice.
About the authors
Yu. Yu. Dyshchirov
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Author for correspondence.
Email: dychshirov03@gmail.com
ORCID iD: 0009-0004-1976-7823
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
L. A. Mitina
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0002-3563-7293
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
A. M. Zaitsev
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0002-1905-9083
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
S. S. Stepanov
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0001-8804-2237
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
O. N. Kirsanova
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0003-0924-6245
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
O. V. Guts
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0001-5874-2208
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
M. S. Ruban
P. A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Ministry of Health of Russia
Email: dychshirov03@gmail.com
ORCID iD: 0000-0002-1016-2009
Russian Federation, 3 2nd Botkinsky Proezd, Moscow 125284
References
- Schaff L.R., Mellinghoff I.K. Glioblastoma and other primary brain malignancies in adults: a review. JAMA 2023;329(7):574–87. doi: 10.1001/jama.2023.0023
- Massaad E., Smith W.J., Bradley J. et al. Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma. Neuro Oncol 2024;26(9):1660–9. doi: 10.1093/neuonc/noae073
- Rivera M., Norman S., Sehgal R., Juthani R. Updates on surgical management and advances for brain tumors. Curr Oncol Rep 2021;23(3):35. doi: 10.1007/s11912-020-01005-7
- Cepeda S., Esteban-Sinovas O., Singh V. et al. Deep learning-based glioma segmentation of 2d intraoperative ultrasound images: a multicenter study using the brain tumor intraoperative ultrasound database (BraTioUS). Cancers (Basel) 2025;17(2):315. doi: 10.3390/cancers17020315
- Dixon L., Lim A., Grech-Sollars M. et al. Intraoperative ultrasound in brain tumor surgery: a review and implementation guide. Neurosurg Rev 2022;45(4):2503–15. doi: 10.1007/s10143-022-01778-4
- Cepeda S., Esteban-Sinovas O., Romero R. et al. Real-time brain tumor detection in intraoperative ultrasound: From model training to deployment in the operating room. Comput Biol Med 2025;193:110481. doi: 10.1016/j.compbiomed.2025.110481
- De Quintana-Schmidt C., Salgado-Lopez L., Aibar-Duran J.A. et al. Neuronavigated ultrasound in neuro-oncology: a true real-time intraoperative image. World Neurosurg 2022;157:e316–26. doi: 10.1016/j.wneu.2021.10.082
- Palavani L.B., Ferreira M.Y., Borges P.G.L.B. et al. Ultrasound-guided resection of high-grade gliomas: a single-arm meta-analysis. World Neurosurg 2024;186:17–26. doi: 10.1016/j.wneu.2024.03.033
- Wei R., Chen H., Cai Y., Chen J. Application of intraoperative ultrasound in the resection of high-grade gliomas Front Neurol 2023;14:1240150. doi: 10.3389/fneur.2023.1240150
- Prada F., Ciocca R., Corradino N. et al. Multiparametric intraoperative ultrasound in oncological neurosurgery: a pictorial essay. Front Neurosci 2022;16:881661. doi: 10.3389/fnins.2022.881661
- Prada F., Vetrano I.G., Gennari A.G. et al. How to perform intra-operative contrast-enhanced ultrasound of the brain – a WFUMB position paper. Ultrasound Med Biol 2021;47(8):2006–16. doi: 10.1016/j.ultrasmedbio.2021.04.016
- Lekht I., Brauner N., Bakhsheshian J. et al. Versatile utilization of real-time intraoperative contrast-enhanced ultrasound in cranial neurosurgery: technical note and retrospective case series. Neurosurg Focus 2016;40(3):E6. doi: 10.3171/2015.11.FOCUS15570
- Kumar M., Noronha S., Rangaraj N. et al. Choice of intraoperative ultrasound adjuncts for brain tumor surgery. BMC Med Inform Decis Mak 2022;22(1):307. doi: 10.1186/s12911-022-02046-7
- Pirri C., Pirri N, Macchi V. et al. Intraoperative ultrasound in brain and spine surgery: current applications, translational value and future perspectives. NeuroSci 2025;6(4):113. doi: 10.3390/neurosci6040113
- Murillo Ponce C., Catillo-Rangel C. et al. Intraoperative ultrasound: an old but ever new technology for a more personalized approach to brain tumor surgery. Cureus 2024;16(6):e62278. doi: 10.7759/cureus.62278
- El Beltagy M.A., Elbaroody M. The value of intraoperative ultrasound in brain surgery. Adv Tech Stand Neurosurg 2024;50:185–99. doi: 10.1007/978-3-031-53578-9_6
- McCracken D.J., Schupper A.J., Lakomkin N. et al. Turning on the light for brain tumor surgery: a 5-aminolevulinic acid story. Neuro Oncol 2022;24(Suppl 6):S52–61. doi: 10.1093/neuonc/noac19
- Chen J.-S., Young J.S., Berger M.S. Current and future applications of 5-aminolevulinic acid in neurosurgical oncology. Cancers (Basel) 2025;17(8):1332. doi: 10.3390/cancers17081332
Supplementary files


